Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl

Emerg Microbes Infect. 2020 Dec;9(1):1379-1387. doi: 10.1080/22221751.2020.1775130.

Abstract

Balamuthia amoebic encephalitis has a subacute-to-chronic course and is almost invariably fatal owing to delayed diagnosis and a lack of effective therapy. Here, we report a 13-year-old girl with cutaneous lesions and multifocal granulomatous encephalitis. The patient underwent a series of tests and was suspected as having tuberculosis. She was treated with various empiric therapies without improvement. She was finally correctly diagnosed via next-generation sequencing of the cerebrospinal fluid. The patient deteriorated rapidly and died 2 months after being diagnosed with Balamuthia mandrillaris encephalitis. This study highlights the important clinical significance of next-generation sequencing, which provides better diagnostic testing for unexplained paediatric encephalitis, especially that caused by rare or emerging pathogens.

Keywords: Balamuthia mandrillaris; Balamuthia amoebic encephalitis; children; granulomatous amebic encephalitis; next-generation sequencing.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amebiasis / diagnostic imaging
  • Amebiasis / drug therapy
  • Amebiasis / parasitology*
  • Antiprotozoal Agents / therapeutic use
  • Balamuthia mandrillaris / genetics
  • Balamuthia mandrillaris / isolation & purification*
  • Encephalitis / diagnostic imaging
  • Encephalitis / drug therapy
  • Encephalitis / parasitology*
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans

Substances

  • Antiprotozoal Agents